South Korea's ADEL Innovates With Anti-Tau Antibody For Alzheimer’s Disease
Executive Summary
Emerging Company Profile: ADEL Inc. CEO Seung-Yong Yoon tells Scrip how its anti-tau antibody brings something different to the table in the challenging field of Alzheimer's disease and what's in store for the South Korean bioventure.